441-02753 Health
Petition to the Government of Canada
Whereas:
An estimated twenty-seven Canadians are diagnosed with a brain tumour each day;
Less than three in ten Canadians diagnosed with a primary malignant brain tumour survive five years after their diagnosis;
Brain cancer research is critically underfunded in Canada;
Canada is years behind the United States in approving new drugs and treatments, which could have an impact on thousands of brain cancer patients;
Even when new brain cancer therapies are approved, they are not always made equally accessible to patients across the country; and
There continues to be a shortage of brain cancer drugs in Canada, and some medications even become discontinued.
We, the undersigned citizens and residents of Canada, call upon the Government of Canada to:
1. Increase funding for brain cancer research;
2. Work with the provinces and territories to ensure that drugs, medical devices, and new therapies are accessible to brain cancer patients nation-wide; and
3. Remove unnecessary red tape so brain cancer drugs can be approved more quickly.
Whereas:
An estimated twenty-seven Canadians are diagnosed with a brain tumour each day;
Less than three in ten Canadians diagnosed with a primary malignant brain tumour survive five years after their diagnosis;
Brain cancer research is critically underfunded in Canada;
Canada is years behind the United States in approving new drugs and treatments, which could have an impact on thousands of brain cancer patients;
Even when new brain cancer therapies are approved, they are not always made equally accessible to patients across the country; and
There continues to be a shortage of brain cancer drugs in Canada, and some medications even become discontinued.
We, the undersigned citizens and residents of Canada, call upon the Government of Canada to:
1. Increase funding for brain cancer research;
2. Work with the provinces and territories to ensure that drugs, medical devices, and new therapies are accessible to brain cancer patients nation-wide; and
3. Remove unnecessary red tape so brain cancer drugs can be approved more quickly.